Lithuanian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
6 rezultatus
Galanin receptor (GALR2) binding assay
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
STATEMENT REGARDING FEDERALLY-SPONSORED R&D
Not applicable
REFERENCE TO MICROFICHE APPENDIX
Not applicable
FIELD OF THE INVENTION
This invention relates to a novel galanin receptor, designated GALR2, to nucleotides encoding it, and to assays which use it.
BACKGROUND OF THE INVENTION
Although
Nucleic acid encoding mouse galanin receptor (GALR2)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
STATEMENT REGARDING FEDERALLY-SPONSORED R&D
Not applicable
REFERENCE TO MICROFICHE APPENDIX
Not applicable
FIELD OF THE INVENTION
This invention relates to a novel galanin receptor, designated GALR2, to nucleotides encoding it, and to assays which use it.
BACKGROUND OF THE INVENTION
Although
Nucleic acid encoding rat galanin receptor (GALR2)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
This invention relates to a novel galanin receptor, designated GALR2, to nucleotides encoding it, and to assays which use it.
BACKGROUND OF THE INVENTION
Although first isolated from porcine intestine, galanin is widely distributed in the central and peripheral nervous system.
Nucleotide encoding human galanin receptor 3 (GALR3)
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
STATEMENT REGARDING FEDERALLY-SPONSORED R&D
Not applicable
REFERENCE TO MICROFICHE APPENDIX
Not applicable
FIELD OF THE INVENTION
This invention relates to a novel galanin receptor, designated GALR3, to nucleotides encoding same, and to assays making use thereof.
BACKGROUND OF THE
Identification of cyclic peptide agonists of galanin receptor 2 and 3 guided by spexin solution structure
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present disclosure relates to cyclic peptide agonists of human galanin receptor 2 (GalR2) and galanin receptor 3 (GalR3) and methods of preparation and use in the treatment of spexin-deficient disorders thereof. More particularly, present disclosure provides cyclic peptide
1,4-dithiin and 1,4-dithiepin-1,1,4,4, tetroxide derivatives useful as antagonists of the human galanin receptor
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
This invention relates to a series of 1,4-dithiin- and 1,4-dithiepin-1,1,4,4-tetroxide derivatives and their use for the treatment of central nervous system disorders and affective conditions. More particularly, the compounds of the invention are ligands for the human galanin
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
- Dirba 55 kalbomis
- Žolelių gydymas, paremtas mokslu
- Vaistažolių atpažinimas pagal vaizdą
- Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
- Skaitykite mokslines publikacijas, susijusias su jūsų paieška
- Ieškokite vaistinių žolelių pagal jų poveikį
- Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais
